Medication info
Rosabesil Tablet 10/50 mg (Amlodipine, Losartan Potassium)

Rosabesil Tablet 10/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›13.888mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Gunil Biopharm Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202002055 · Approved 2020.03.24 · Insurance code 073000600

Summary

Main use
Treatment of essential hypertension and stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either ingredient, switching directly to this medicine may be considered as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients who are taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretic therapy). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, this medicine is not recommended as initial therapy.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Gunil Biopharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Amlodipine or Losartan, or in patients with stage 2 hypertension who require combination therapy to achieve target blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using either ingredient, switching directly to this medicine may be considered as follows: - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients who are taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with combination therapy compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: Dose adjustment is not necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretic therapy). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or over, an initial losartan dose of 25 mg once daily is recommended; therefore, this medicine is not recommended as initial therapy.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medicine can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Hypotensive symptoms may occur when administering this drug initially to patients with low blood volume, so these patients should manage their blood volume prior to administration. Patients who are allergic to any of the ingredients of this medication or who have severe liver diseases, aortic stenosis, or are in a state of shock should not take this drug. Patients with decreased blood volume, strict salt restrictions, or moderate to severe renal impairment should use this drug cautiously. Dizziness or drowsiness may occur during treatment; therefore, caution should be taken when driving or operating hazardous machinery. This medication may affect liver and kidney function; therefore, patients with liver or kidney diseases should undergo regular check-ups as directed by their physician. Care should be taken if taken with other antihypertensive drugs or potassium-sparing diuretics as potassium levels may increase. It is advisable not to take this medicine while breastfeeding, and it is not recommended for children under 18 years of age as safety and efficacy have not been established. Overdose may cause severe hypotension and cardiac issues, so it is important to adhere precisely to the dosage and seek immediate medical attention in case of overdose. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pit edema
Show 162 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • itching
  • rash
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • frequent urination
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension
  • sensory impairment
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste abnormality
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urination frequency
  • urination disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • skin erythema
  • maculopapular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus obstruction
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • decreased appetite
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscular rigidity
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory decrease
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic hypersensitivity
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • nosebleeds
  • respiratory congestion
  • dermatitis
  • skin dryness
  • petechia
  • erythema
  • photosensitivity
  • sweating
  • blurred vision
  • eye burning
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • urethral infection
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • liver dysfunction
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste disorder
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • low blood pressure
  • shock symptoms
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is important to maintain the storage temperature between 1 and 30 degrees Celsius to preserve the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.